The results of several studies have demonstrated that the expression of TS functions as a key determinant of fluorpyrimidine sensitivity, and preclinical in vitro and in vivo studies have elucidated an inverse relationship between TS expression in cancer cells and fluoropyrimidine sensitivity [15]–[18]. The gene discussed is TYMS; the disease is cancer.